Proof-of-concept study evaluates MR-guided multidrug-eluting microdevice placement in high-risk prostate cancer, highlighting feasibility for in situ systemic therapy testing.
To assess safety and feasibility of percutaneous MR-guided placement of an implantable microdevice (IMD) to evaluate
No takes yet. Share an insight, caveat, or question.
Stone et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: